4.
厄洛替尼治疗114例晚期复治NSCLC肺癌患者的不良反应
The side effects of Erlotinib as second line treatment for 114 patient with recurrent non-small cell lung cancer
| Toxicities | Toxic side effects | n (%) | |||
| 1 | 2 | 3 | 4 | ||
| Rash | 36 | 29 | 8 | 0 | 73 (64.0) |
| Diarrhea | 46 | 11 | 2 | 0 | 59 (51.8) |
| Anorexia | 10 | 2 | 0 | 0 | 12 (10.5) |
| Fatigue | 13 | 3 | 0 | 0 | 16 (14.0) |
| Hematologic | 11 | 2 | 0 | 0 | 13 (11.4) |
| Hepatic | 9 | 1 | 0 | 0 | 10 (8.8) |
| Interstitial lung disease | 1 | 1 | 0 | 0 | 2 (1.8) |